LYMPHOMAS
Clinical trials for LYMPHOMAS explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMAS trials appear
Sign up with your email to follow new studies for LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a new drug called FF-10502-01 in 106 people with advanced solid tumors or lymphomas that had stopped responding to standard treatments. The goal was to find the safest dose and see if the drug could shrink tumors or slow disease progression. The study is now com…
Matched conditions: LYMPHOMAS
Phase: PHASE1, PHASE2 • Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New drug combo tested in Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested the safety of combining two cancer drugs, bortezomib and clofarabine, in 28 adults with advanced solid tumors, lymphomas, or myelodysplastic syndromes that had stopped responding to standard treatments. Participants received the drugs in 21-day cycle…
Matched conditions: LYMPHOMAS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC